About Anastrazole Elinal of Emcure
Experience excellent savings and exclusive market value with Elinal (Anastrazole) by Emcure. This stellar oncology medication is designed as an unassailable therapeutic choice for breast cancer treatment in postmenopausal women. Manufactured to meet international and domestic standards, Elinal contains a potent 1 mg dose of anastrazole per round, white, scored tablet. With each box containing 10 strips (10 tablets per strip), this branded prescription-only drug is authorized by Indian regulatory authorities, ensuring quality and reliability. Take advantage of assured efficacy and trusted distribution for both suppliers and traders. Highly recommended for use under physician guidance only.
Comprehensive Oncology Use & Application Highlights
Elinal (Anastrazole), intended for oral use only, is prescribed for the treatment of breast cancer in postmenopausal women. As a powerful aromatase inhibitor, its primary application lies within oncology, providing therapeutic benefits exclusively under medical supervision. This product is suitable for adult female patients and must be used exactly as directed by healthcare professionals. For optimal outcomes, its use type is strictly prescribed, ensuring each administration aligns with physician guidance and patient-specific requirements.
Efficient Delivery, Market Reach & Distribution Policy
Elinal is efficiently dispatched to both domestic and international markets, reflecting a robust supply ability for distributors, suppliers, and traders across India. Orders are delivered promptly, with packaging designed to preserve product integrity during transit. Samples are available based on policy, facilitating evaluation before bulk procurement. Customers seeking market value can rely on trusted, swift logistics for timely delivery, supporting the on-time availability of this high-value oncology medication in clinical and retail settings.
FAQ's of Anastrazole Elinal of Emcure:
Q: How should Elinal (Anastrazole) be stored to maintain efficacy?
A: Elinal should be stored below 30C, protected from moisture and light, and kept in its original packaging until use to preserve its quality and efficacy.
Q: What are the main indications for using Elinal?
A: Elinal is indicated for the treatment of breast cancer in postmenopausal women, as prescribed by a healthcare provider. It is not intended for pre-menopausal women or pregnant patients.
Q: When should Elinal tablets be taken for optimal effectiveness?
A: Elinal is typically taken once daily, at the same time each day, or as prescribed by your physician to ensure maximum effectiveness of the treatment.
Q: Where is Elinal approved for distribution and use?
A: Elinal is approved by the drug regulatory authorities in India and is distributed to both domestic and international markets through verified suppliers, traders, and distributors.
Q: What side effects can be expected when using Elinal?
A: Common side effects include hot flashes, joint pain, weakness, and nausea. It's important to inform your healthcare provider if any adverse effects are experienced.
Q: How can healthcare providers or distributors request samples of Elinal?
A: Samples of Elinal may be provided according to the distributor's sample policy. Interested parties should contact their Emcure representative or authorized distributor for further details.